{
  "id": "cluster_4_doc2",
  "content": "Provider report from Dr. Alvaro Mendoza: 68-year-old patient presenting with Erdheim-Chester disease (PH-7284-J) showed 40% tumor reduction post-6 cycles. Next genomic sequencing scheduled January 15th at Northwestern Precision Medicine Hub under research grant GNM-2280.",
  "metadata": {
    "format": "provider_report"
  }
}